Retrospective study identifies imaging biomarkers for AMD progression using machine learning models
A retrospective cohort study analyzed 324 patients with age-related macular degeneration (AMD) to develop machine learning models predicting progression from early to late AMD stages over 3 years. The study used multimodal fundus images but did not report specific interventions, comparators, or study setting. The analysis identified pigmentary abnormalities, total drusen area in the macular region, and ellipsoid zone characteristics as independent risk factors for progression (P < 0.05), while subfoveal choroidal thickness and choroidal capillary blood flow density were protective factors (P < 0.05).
Four machine learning models were evaluated: Random Forest achieved an AUC of 0.779 in training and 0.700 in validation; XG BOOST showed 0.702 in training and 0.762 in validation; Support Vector Machine reached 0.768 in training and 0.646 in validation; and K-Nearest Neighbor performed at 0.717 in training and 0.596 in validation. The study did not report effect sizes, absolute numbers, or confidence intervals for the identified factors.
Safety and tolerability data were not reported. Key limitations include the retrospective design, single-center nature, absence of external validation, and modest model performance in the validation set. The study did not report funding sources or conflicts of interest. These findings represent associations rather than causal relationships and should be interpreted cautiously until validated in prospective, multicenter studies with diverse populations.